CardioSignal

Company profile

About CardioSignal

CardioSignal, developed by Precordior, is a medical software company that has developed a CE-marked Class IIb medical device for detecting atrial fibrillation using smartphone technology. The company's patented gyrocardiography technology utilizes motion sensors built into smartphones to assess precordial micro-vibrations caused by cardiac motion, enabling users to check their heart health in just 60 seconds from anywhere. Based on over 12 years of academic research and validated in clinical studies with 96% accuracy, CardioSignal serves multiple market segments including direct-to-consumer self-monitoring, healthcare providers and insurance companies for population health programs, pharmaceutical companies and CROs for clinical research, and point-of-care clinical settings. The technology has been documented in over 20 peer-reviewed publications and used by more than 200,000 people. CardioSignal is available across 16 European countries and India, offering subscription-based access starting at €3.7 per month. The company is ISO27001-certified for information security and ISO13485-certified as a medical device manufacturer. CardioSignal recently achieved MDR Class IIb certification and is launching CardioSignal Inside, an SDK partnership model that allows B2B partners to integrate the medical-grade atrial fibrillation detection directly into their own mobile applications.

Company description · CardioSignal official website